🇦🇹 Austria Country × Condition
coronary artery disease Clinical Trials in Austria
Active clinical trials for coronary artery disease with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT06074549
Recruiting
DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System
Enrollment
5,000 pts
Country
🇦🇹 Austria
Elixir Medical Corporation
View Trial → NCT05427370
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Enrollment
754 pts
Country
🇦🇹 Austria
Sunnybrook Health Sciences Centre
View Trial → Frequently Asked Questions
How many coronary artery disease clinical trials are active in Austria?
There are currently 2 active clinical trials for coronary artery disease with sites in Austria, of which 2 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in Austria?
To join a coronary artery disease clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in Austria?
Active coronary artery disease trials in Austria span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology